These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
342 related items for PubMed ID: 18202778
1. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling. Zhao J, Leonard C, Gemsenjäger E, Heitz PU, Moch H, Odermatt B. Oncol Rep; 2008 Feb; 19(2):329-37. PubMed ID: 18202778 [Abstract] [Full Text] [Related]
2. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays. Zhao J, Leonard C, Brunner E, Gemsenjäger E, Heitz PU, Odermatt B. Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634 [Abstract] [Full Text] [Related]
3. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. Chevillard S, Ugolin N, Vielh P, Ory K, Levalois C, Elliott D, Clayman GL, El-Naggar AK. Clin Cancer Res; 2004 Oct 01; 10(19):6586-97. PubMed ID: 15475448 [Abstract] [Full Text] [Related]
4. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas. Bryson PC, Shores CG, Hart C, Thorne L, Patel MR, Richey L, Farag A, Zanation AM. Arch Otolaryngol Head Neck Surg; 2008 Jun 01; 134(6):581-6. PubMed ID: 18559722 [Abstract] [Full Text] [Related]
5. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias. Belge G, Meyer A, Klemke M, Burchardt K, Stern C, Wosniok W, Loeschke S, Bullerdiek J. Genes Chromosomes Cancer; 2008 Jan 01; 47(1):56-63. PubMed ID: 17943974 [Abstract] [Full Text] [Related]
6. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms. Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A. Surgery; 2005 Dec 01; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397 [Abstract] [Full Text] [Related]
7. Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Barden CB, Shister KW, Zhu B, Guiter G, Greenblatt DY, Zeiger MA, Fahey TJ. Clin Cancer Res; 2003 May 01; 9(5):1792-800. PubMed ID: 12738736 [Abstract] [Full Text] [Related]
8. Molecular analysis of minimally invasive follicular carcinomas by gene profiling. Lubitz CC, Gallagher LA, Finley DJ, Zhu B, Fahey TJ. Surgery; 2005 Dec 01; 138(6):1042-8; discussion 1048-9. PubMed ID: 16360389 [Abstract] [Full Text] [Related]
9. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors. Puskas LG, Juhasz F, Zarva A, Hackler L, Farid NR. Cell Mol Biol (Noisy-le-grand); 2005 Sep 05; 51(2):177-86. PubMed ID: 16171553 [Abstract] [Full Text] [Related]
10. Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression. Stolf BS, Santos MM, Simao DF, Diaz JP, Cristo EB, Hirata R, Curado MP, Neves EJ, Kowalski LP, Carvalho AF. Cancer; 2006 May 01; 106(9):1891-900. PubMed ID: 16565969 [Abstract] [Full Text] [Related]
11. Molecular markers for discrimination of benign and malignant follicular thyroid tumors. Fryknäs M, Wickenberg-Bolin U, Göransson H, Gustafsson MG, Foukakis T, Lee JJ, Landegren U, Höög A, Larsson C, Grimelius L, Wallin G, Pettersson U, Isaksson A. Tumour Biol; 2006 May 01; 27(4):211-20. PubMed ID: 16675914 [Abstract] [Full Text] [Related]
12. Identification of borderline thyroid tumors by gene expression array analysis. Arora N, Scognamiglio T, Lubitz CC, Moo TA, Kato MA, Zhu B, Zarnegar R, Chen YT, Fahey TJ. Cancer; 2009 Dec 01; 115(23):5421-31. PubMed ID: 19658182 [Abstract] [Full Text] [Related]
13. Significance of trisomy 7 and 12 in thyroid lesions with follicular differentiation: a cytogenetic and in situ hybridization study. Roque L, Serpa A, Clode A, Castedo S, Soares J. Lab Invest; 1999 Apr 01; 79(4):369-78. PubMed ID: 10211989 [Abstract] [Full Text] [Related]
14. Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions. Cho Mar K, Eimoto T, Tateyama H, Arai Y, Fujiyoshi Y, Hamaguchi M. Histopathology; 2006 Feb 01; 48(3):286-94. PubMed ID: 16430475 [Abstract] [Full Text] [Related]
15. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression. Rosen J, He M, Umbricht C, Alexander HR, Dackiw AP, Zeiger MA, Libutti SK. Surgery; 2005 Dec 01; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390 [Abstract] [Full Text] [Related]
16. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma. Savin S, Cvejic D, Isic T, Paunovic I, Tatic S, Havelka M. Exp Oncol; 2006 Mar 01; 28(1):70-4. PubMed ID: 16614712 [Abstract] [Full Text] [Related]
17. Genetic markers differentiating follicular thyroid carcinoma from benign lesions. Freitas BC, Cerutti JM. Mol Cell Endocrinol; 2010 May 28; 321(1):77-85. PubMed ID: 19932149 [Abstract] [Full Text] [Related]
18. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma. Umbricht CB, Saji M, Westra WH, Udelsman R, Zeiger MA, Sukumar S. Cancer Res; 1997 Jun 01; 57(11):2144-7. PubMed ID: 9187112 [Abstract] [Full Text] [Related]
19. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Mehrotra P, Okpokam A, Bouhaidar R, Johnson SJ, Wilson JA, Davies BR, Lennard TW. Histopathology; 2004 Nov 01; 45(5):493-500. PubMed ID: 15500653 [Abstract] [Full Text] [Related]
20. [Differential gene expression signatures in well differentiated thyroid carcinomas]. Heitz PU, Zhao J, Leonard-Meier Ch, Gemsenjäger E, Odermatt B, Brunner E. Verh Dtsch Ges Pathol; 2003 Nov 01; 87():185-7. PubMed ID: 16888911 [Abstract] [Full Text] [Related] Page: [Next] [New Search]